Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024

Description

Subcutaneous immunoglobulin (SCIG) refers to a method of administering immunoglobulin therapy where the medication is injected under the skin, rather than into a vein. This approach allows for slower absorption of the medication, which can reduce the risk of side effects compared to intravenous administration. SCIG is commonly used to treat various immune deficiencies, providing a convenient and effective way to boost the immune system.

The main types of SCIG products include immunoglobulin A (IgA), immunoglobulin G (IgG), and immunoglobulin M (IgM). IgA is an antibody type crucial for immune defense at mucosal surfaces, helping prevent pathogens from entering the body through mucosal membranes. These products find applications in primary immunodeficiency disorders, autoimmune diseases, neurological disorders, and other conditions, and they are used by various end-users such as clinics, hospitals, homecare settings, and others.

The subcutaneous immunoglobulin (SCIG) market research report is one of a series of new reports from The Business Research Company that provides subcutaneous immunoglobulin (SCIG) market statistics, including the subcutaneous immunoglobulin (SCIG) industry global market size, regional shares, competitors with subcutaneous immunoglobulin (SCIG) market share, detailed subcutaneous immunoglobulin (SCIG) market segments, market trends, and opportunities, and any further data you may need to thrive in the subcutaneous immunoglobulin (SCIG) industry. These subcutaneous immunoglobulin (SCIG) market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The subcutaneous immunoglobulin market size has grown rapidly in recent years. It will grow from $11.19 billion in 2023 to $12.72 billion in 2024 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to the increased prevalence of immunodeficiency disorders, a rise in patient preference for home-based care, enhanced therapeutic efficacy, growth in awareness and diagnosis rates, and favorable reimbursement policies.

The subcutaneous immunoglobulin market size is expected to see rapid growth in the next few years. It will grow to $21.38 billion in 2028 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to the growing prevalence of neurological disorders, increasing prevalence of autoimmune diseases, rising awareness and acceptance of immunoglobulin therapy, expanding applications in neurology and dermatology, and the expansion of healthcare facilities. Major trends in the forecast period include advancements in drug delivery systems, increasing demand for home infusion therapies, developments in antibody therapy, innovations in formulations, and advancements in SCIG technology.

The rising prevalence of secondary immunodeficiency diseases is expected to drive the growth of the subcutaneous immunoglobulin market in the future. Secondary immunodeficiency diseases are characterized by a compromised immune system due to factors other than inherent immune system deficiencies. This prevalence is fueled by factors such as aging populations, the use of immunosuppressive therapies, and exposure to environmental toxins. Subcutaneous immunoglobulin therapy delivers antibodies to bolster the weakened immune system, particularly in chronic conditions such as HIV or autoimmune disorders, thereby preventing infections and supporting immune function during treatment. For example, in October 2023, the UK Health Security Agency reported 3,805 new HIV diagnoses in England in 2022, marking a 22% increase from the previous year. Hence, the rising prevalence of secondary immunodeficiency diseases is propelling the growth of the subcutaneous immunoglobulin market.

The growing incidence of neurological disorders is also expected to contribute to the expansion of the subcutaneous immunoglobulin market. Neurological disorders encompass a range of conditions affecting the nervous system, characterized by anatomical, biochemical, or electrical abnormalities in the brain, spinal cord, or peripheral nerves. Factors such as aging populations, environmental pollutants, genetic predispositions, and lifestyle changes contribute to the increasing prevalence of neurological disorders. Subcutaneous immunoglobulin therapy can be beneficial in these disorders by providing antibodies that modulate immune responses, reduce inflammation, and stabilize neuromuscular junctions, potentially slowing disease progression and improving symptoms. For instance, according to the Alzheimer's Association, 6.5 million Americans aged 65 and older are living with Alzheimer's dementia, with projections suggesting this number could double to 13.8 million by 2060. Hence, the rising number of neurological disorders is driving the growth of the subcutaneous immunoglobulin market.

Leading companies in the subcutaneous immunoglobulin market are developing subcutaneous human immunoglobulin (SCIG) formulations to enhance their product portfolios and offer more treatment options for patients with primary immunodeficiency diseases. SCIG refers to human immunoglobulin formulations for subcutaneous administration, designed specifically for treating primary immunodeficiency diseases. For example, in March 2022, Grifols S.A. introduced XEMBIFY 20% SCIG, a ready-to-use formulation for treating primary immunodeficiency, addressing a significant medical need for individuals with weakened immune systems. XEMBIFY offers simplified treatment procedures and increased patient convenience, as it remains stable at room temperature for up to 24 months, eliminating the need for refrigeration during storage and transport, which is advantageous in various healthcare settings.

Major companies operating in the subcutaneous immunoglobulin (SCIG) market are Pfizer Inc., Johnson & Johnson, Prothena Corporation plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Baxter International Inc., CSL Behring, Lonza Group, Grifols S.A., Octapharma AG, Dr. Reddy's Laboratories, Intas pharmaceutical Ltd., Emergent BioSolutions Inc., Kedrion Biopharma, LFB group, Biotest AG, Argenx SE, Bio Products Laboratory Ltd., ADMA Biologics Inc., Sino Biological Inc. , Bharat Serums and Vaccines Limited (BSV), Kamada Pharmaceuticals, CinnaGen Co., Shire plc

North America was the largest region in the subcutaneous immunoglobulin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the subcutaneous immunoglobulin (SCIG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the subcutaneous immunoglobulin (SCIG) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The subcutaneous immunoglobulin (SCIG) market consists of revenues earned by entities by providing services such as immune system support, home-based therapy, infection prevention, personalized dosing, patient training, and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The subcutaneous immunoglobulin market also includes sales of infusion pumps, needles and catheters, syringes, and sharps disposal containers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Immunoglobulin (SCIG) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on subcutaneous immunoglobulin (scig) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous immunoglobulin (scig) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The subcutaneous immunoglobulin (scig) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Immunoglobulin A (IgA); Immunoglobulin G (IgG); Immunoglobulin M (IgM)
2) By Application: Primary Immunodeficiency Disorders; Autoimmune Diseases; Neurological Disorders; Other Applications
3) By End-Use: Clinics; Hospitals; Homecare; Other End-Uses
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Prothena Corporation plc; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18486

1. Executive Summary

2. Subcutaneous Immunoglobulin (SCIG) Market Characteristics

3. Subcutaneous Immunoglobulin (SCIG) Market Trends And Strategies

4. Subcutaneous Immunoglobulin (SCIG) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Subcutaneous Immunoglobulin (SCIG) Market Size and Growth

5.1. Global Subcutaneous Immunoglobulin (SCIG) Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Subcutaneous Immunoglobulin (SCIG) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Subcutaneous Immunoglobulin (SCIG) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Subcutaneous Immunoglobulin (SCIG) Market Segmentation

6.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Immunoglobulin A (IgA)
Immunoglobulin G (IgG)
Immunoglobulin M (IgM)
6.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Primary Immunodeficiency Disorders
Autoimmune Diseases
Neurological Disorders
Other Applications
6.3. Global Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Clinics
Hospitals
Homecare
Other End-Uses

7. Subcutaneous Immunoglobulin (SCIG) Market Regional And Country Analysis

7.1. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Subcutaneous Immunoglobulin (SCIG) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market

8.1. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Subcutaneous Immunoglobulin (SCIG) Market

9.1. China Subcutaneous Immunoglobulin (SCIG) Market Overview
9.2. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Subcutaneous Immunoglobulin (SCIG) Market

10.1. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Subcutaneous Immunoglobulin (SCIG) Market

11.1. Japan Subcutaneous Immunoglobulin (SCIG) Market Overview
11.2. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Subcutaneous Immunoglobulin (SCIG) Market

12.1. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Subcutaneous Immunoglobulin (SCIG) Market

13.1. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Subcutaneous Immunoglobulin (SCIG) Market

14.1. South Korea Subcutaneous Immunoglobulin (SCIG) Market Overview
14.2. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Subcutaneous Immunoglobulin (SCIG) Market

15.1. Western Europe Subcutaneous Immunoglobulin (SCIG) Market Overview
15.2. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Subcutaneous Immunoglobulin (SCIG) Market

16.1. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Subcutaneous Immunoglobulin (SCIG) Market

17.1. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Subcutaneous Immunoglobulin (SCIG) Market

18.1. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Subcutaneous Immunoglobulin (SCIG) Market

19.1. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Subcutaneous Immunoglobulin (SCIG) Market

20.1. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market

21.1. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market Overview
21.2. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Subcutaneous Immunoglobulin (SCIG) Market

22.1. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Subcutaneous Immunoglobulin (SCIG) Market

23.1. North America Subcutaneous Immunoglobulin (SCIG) Market Overview
23.2. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Subcutaneous Immunoglobulin (SCIG) Market

24.1. USA Subcutaneous Immunoglobulin (SCIG) Market Overview
24.2. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Subcutaneous Immunoglobulin (SCIG) Market

25.1. Canada Subcutaneous Immunoglobulin (SCIG) Market Overview
25.2. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Subcutaneous Immunoglobulin (SCIG) Market

26.1. South America Subcutaneous Immunoglobulin (SCIG) Market Overview
26.2. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Subcutaneous Immunoglobulin (SCIG) Market

27.1. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Subcutaneous Immunoglobulin (SCIG) Market

28.1. Middle East Subcutaneous Immunoglobulin (SCIG) Market Overview
28.2. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Subcutaneous Immunoglobulin (SCIG) Market

29.1. Africa Subcutaneous Immunoglobulin (SCIG) Market Overview
29.2. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Subcutaneous Immunoglobulin (SCIG) Market, Segmentation By End-Use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape And Company Profiles

30.1. Subcutaneous Immunoglobulin (SCIG) Market Competitive Landscape
30.2. Subcutaneous Immunoglobulin (SCIG) Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Prothena Corporation plc
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. GlaxoSmithKline plc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Takeda Pharmaceutical Company Limited
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Subcutaneous Immunoglobulin (SCIG) Market Other Major And Innovative Companies

31.1. Amgen Inc.
31.2. Baxter International Inc.
31.3. CSL Behring
31.4. Lonza Group
31.5. Grifols S.A.
31.6. Octapharma AG
31.7. Dr. Reddy's Laboratories
31.8. Intas pharmaceutical Ltd.
31.9. Emergent BioSolutions Inc.
31.10. Kedrion Biopharma
31.11. LFB group
31.12. Biotest AG
31.13. Argenx SE
31.14. Bio Products Laboratory Ltd.
31.15. ADMA Biologics Inc.

32. Global Subcutaneous Immunoglobulin (SCIG) Market Competitive Benchmarking

33. Global Subcutaneous Immunoglobulin (SCIG) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Subcutaneous Immunoglobulin (SCIG) Market

35. Subcutaneous Immunoglobulin (SCIG) Market Future Outlook and Potential Analysis

35.1 Subcutaneous Immunoglobulin (SCIG) Market In 2028 - Countries Offering Most New Opportunities
35.2 Subcutaneous Immunoglobulin (SCIG) Market In 2028 - Segments Offering Most New Opportunities
35.3 Subcutaneous Immunoglobulin (SCIG) Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer